e8vk
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 23, 2008
ENDOLOGIX, INC.
(Exact name of registrant as specified in its charter)
| |
|
|
|
|
| Delaware
|
|
000-28440
|
|
68-0328265 |
| (State or other
jurisdiction of
incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.) |
| |
|
|
| 11 Studebaker, Irvine, CA
|
|
92618 |
| (Address of principal executive offices)
|
|
(Zip Code) |
Registrant’s telephone number, including area code: (949) 595-7200
Check the appropriate box below if the Form 8-K filing is intended to be simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
TABLE OF CONTENTS
Item 2.02 Results of Operations and Financial Condition.
On October 23, 2008, Endologix, Inc. issued a press release to report its financial results
for the three and nine months ended September 30, 2008. The press release is furnished as Exhibit
99.1 and is incorporated herein by reference.
On October 23, 2008, Endologix, Inc. held a conference call with analysts and investors, the
transcript of which is furnished as Exhibit 99.2 and is incorporated herein by reference.
The information in this Current Report on Form 8-K, including Exhibit 99.1 and 99.2, is
furnished pursuant to Item 2.02 and shall not be deemed “filed” for the purposes of Section 18 of
the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that
section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of
1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| |
|
|
| Exhibit Number |
|
Description |
99.1
|
|
Press Release dated October 23, 2008. |
99.2
|
|
Transcript of Conference Call held on October 23, 2008. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| |
|
|
|
|
| |
ENDOLOGIX, INC.
|
|
| October 27, 2008 |
/s/ Robert J. Krist
|
|
| |
Robert J. Krist |
|
| |
Chief Financial Officer |
|
| |
EXHIBIT INDEX
| |
|
|
| Exhibit Number |
|
Description |
99.1
|
|
Press Release dated October 23, 2008. |
99.2
|
|
Transcript of Conference Call held on October 23, 2008. |